Geneos Wealth Management’s First Trust Exchange-Traded Fund VIII First Trust Income Opportunities ETF FCEF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.5K Buy
513
+9
+2% +$209 ﹤0.01% 1948
2025
Q4
$11.6K Buy
504
+9
+2% +$205 ﹤0.01% 1920
2025
Q3
$11.3K Buy
495
+9
+2% +$204 ﹤0.01% 1923
2025
Q2
$10.9K Sell
486
-468
-49% -$10K ﹤0.01% 2288
2025
Q1
$20.7K Buy
954
+485
+103% +$10.6K ﹤0.01% 2302
2024
Q4
$10.1K Buy
+469
New +$10.4K ﹤0.01% 2048

Other funds holding FCEF

Geneos Wealth Management's FCEF Position: Q1 2026 in Review

Geneos Wealth Management increased its First Trust Exchange-Traded Fund VIII First Trust Income Opportunities ETF (FCEF) stake by 1.8% in Q1 2026, buying an estimated $209 and bringing the position to 513 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1948.

Geneos Wealth Management first reported a position in FCEF in Q4 2024 and has held it in 6 quarters since. The position peaked at $20.7K in Q1 2025. 34 funds tracked by Wall St. Rank hold FCEF as of Q1 2026.

  • Geneos Wealth Management held 513 shares of First Trust Exchange-Traded Fund VIII First Trust Income Opportunities ETF worth $11.5K as of Q1 2026.
  • Geneos Wealth Management bought 9 First Trust Exchange-Traded Fund VIII First Trust Income Opportunities ETF shares in Q1 2026, an estimated $209.
  • First Trust Exchange-Traded Fund VIII First Trust Income Opportunities ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1948 holding.
  • Geneos Wealth Management first reported a position in First Trust Exchange-Traded Fund VIII First Trust Income Opportunities ETF in Q4 2024 and has held it in 6 quarters since.
  • Geneos Wealth Management's First Trust Exchange-Traded Fund VIII First Trust Income Opportunities ETF position peaked at $20.7K in Q1 2025.
  • 34 funds tracked by Wall St. Rank held First Trust Exchange-Traded Fund VIII First Trust Income Opportunities ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.